ArticleThe Journal of experimental medicine2014

Thromboxane A2 acts as tonic immunoregulator by preferential disruption of low-avidity CD4+ T cell-dendritic cell interactions.

Federica Moalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.